Category
»
Primary study
Registry of Trials»ISRCTN registry
Year
»
2021
INTERVENTION: The ROWTATE intervention is a specialist vocational rehabilitation intervention plus usual care. The ROWTATE intervention will be compared to a usual care (control) group. Intervention group: The ROWTATE intervention will be delivered by Occupational Therapists and Clinical Psychologists (if required) who are trained to assess the impact of injury on the participant and their job; coordinate appropriate support from NHS, employer and other stakeholders; negotiate workplace adjustments, monitor return to work and explore alternatives where current work is not feasible or cannot be sustained. It will be tailored to individual needs. Usual care (UC) group: Usual NHS rehabilitation provided by usual care team and may involve primary care, secondary care, community and social services. The intervention will commence within 2 weeks of randomisation and last for as long as is needed up to 12 months post‐randomisation. Participants will be followed up by postal/online questionnaire at 3, 6 and 12 months post‐randomisation. CONDITION: Specialty: Trauma and Emergency Care, Primary sub‐specialty: Emergency Medicine; Health Category: Generic health relevance ; Injury, Occupational Diseases, Poisoning PRIMARY OUTCOME: The number of participants who have returned to employment/full‐time education at >=80% of pre‐injury working hours, 12 months post randomisation self‐reported by the participants via completion of study questionnaires INCLUSION CRITERIA: 1. Aged 16 – 69 years 2. Admitted to a participating MTC within the last 12 weeks with an ISS > 8 at admission 3. In work at time of injury (including self‐employed, full‐time education and voluntary work) 4. Has not returned to work/voluntary work/education 5. No plans to retire within the next year 6. Not participating in other vocational rehabilitation trials 7. Have sufficient proficiency in English to contribute to the data collection required for research or be willing to use an approved interpreting service for data collection 8. Have capacity to provide informed consent to participate in the study 9. Resides in MTC catchment area SECONDARY OUTCOME: ; Measured at 3, 6 and 12 months:; 1. Employment/education outcomes: Work/education intentions, job/education retention, job/education changes (role/course, hours), time to return to work/education, retirement, sickness absence, assessed via bespoke questions; 2. Work limitations (including productivity loss), assessed via the Work Limitation Questionnaire (only for participants who have returned to work); 3. Psychological wellbeing, assessed using the Patient Health Questionnaire (PHQ‐9), the Generalised Anxiety Disorder Assessment (GAD‐7) and the Impact of Events Scale (IES); 4. Health related quality of life, measured using the EuroQol 5 dimension health questionnaire, 5 level (EQ‐5D‐5L); 5. Disability, assessed using the WHODAS 2.0 (at 12 months only); 6. Recovery expectations, assessed using questions developed by Cole and colleagues (3 and 6 months only); 7. Work ability, measured using items from the Work Ability Index (12 months only); 8. Financial impact of injury, measured using the Financial Chronic Stress Scale; 9. Purpose in life, assessed using the Purpose in Life Scale (12 months only); 10. Health and social care resource use and cost effectiveness, measured using a bespoke patient completed resource use questionnaire.; ; 11. Embedded process evaluation and implementation study; Acceptability of the intervention, content of usual care and the intervention, intervention fidelity, competency to deliver the intervention, and facilitators and barriers to the delivery of the intervention will be measured using an embedded mixed‐methods process evaluation and implementation study. This will include using a range of methods including observations, qualitative interviews with participants, service providers, employers, carers, GPs and commissioners, pre and post training questionnaires and document analysis (case records and intervention proformas) in a sample of study participants (who consent to take part).;
Epistemonikos ID: 98967c0f3a0d559de095f049b18c4f4b8293db06
First added on: Aug 25, 2024